Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01381718 · ClinicalTrials.gov registry record · Phase 2
Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
A Phase 2 study, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 112
- Enrollment target
NCT01381718 is a Phase 2 study that has completed, run by University of South Florida. The registered enrollment target is 112 participants.
The verdict
NCT01381718, a Phase 2 study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 112 participants
- Enrollment target
Study Summary
RATIONALE: Modafinil may help improve memory, attention, and fatigue caused by cancer treatment. PURPOSE: This phase II randomized trial studies how well modafinil works in treating children with memory and attention problems caused by cancer treatment for a brain tumor.
Interventions
- OTHER placebo
- DRUG modafinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2011-08 |
| Est. Completion | 2016-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01381718
The ClinicalTrials.gov registry entry for NCT01381718 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01381718 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01381718 about?
NCT01381718 is a clinical study titled "Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor". RATIONALE: Modafinil may help improve memory, attention, and fatigue caused by cancer treatment. PURPOSE: This phase II randomized trial studies how well modafinil works in treating children with memory and attention problems caused by cancer treatment for a brain tumor.
What is the current status of trial NCT01381718?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 112 participants. The study started on 2011-08. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01381718?
The interventions under investigation include: placebo (OTHER), modafinil (DRUG).
Who is sponsoring clinical trial NCT01381718?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.